1,4-Dimercapto-2,3-butanediol → 1-{2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethyl}-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea

HRID 633484

반응식

HRID 633484 반응식
[CH3:1][C@H:2]1[O:7][C@@H:6]([CH3:8])[CH2:5][N:4]([CH2:9][CH2:10][NH:11][C:12]([NH:14][C:15]2[S:16][C:17]3[CH:23]=[C:22]([S:24]C#N)[CH:21]=[CH:20][C:18]=3[N:19]=2)=[O:13])[CH2:3]1.SCC(C(CS)O)O>P([O-])(O)(O)=O.[K+]>[CH3:8][C@H:6]1[O:7][C@@H:2]([CH3:1])[CH2:3][N:4]([CH2:9][CH2:10][NH:11][C:12]([NH:14][C:15]2[S:16][C:17]3[CH:23]=[C:22]([SH:24])[CH:21]=[CH:20][C:18]=3[N:19]=2)=[O:13])[CH2:5]1

참가 물질

4

반응물 2

HCID 190011,4-Dimercapto-2,3-butanediolHCID 866478792-[({2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethyl}carbamoyl)amino]-1,3-benzothiazol-6-yl thiocyanate

생성물 1

HCID 866478781-{2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethyl}-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea수율 99.6%

시약·촉매·용매 1

HCID 516951Monobasic potassium phosphate촉매

실험 절차

The 1-{2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethyl}-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea was prepared according to the method described in Example 1 b, but using 640 mg of 2-[({2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethyl}carbamoyl)amino]-1,3-benzothiazol-6-yl thiocyanate, 7 mg of potassium dihydrogen phosphate and 729 mg of DL-dithiothreitol. 597 mg of 1-{2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethyl}-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea are thus obtained in the form of a white solid, the characteristics of which are as follows:

후처리

  1. customThe 1-{2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethyl}-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea was prepared

출처 및 근거

ORD 기록
ord-d0c291ddb66e4e9786d743cfa30bef95
출처 데이터셋
uspto-grants-2016_04
특허 번호
US09321777B2

연결된 노트

불러오는 중…